These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36070596)

  • 1. Solubility Enhancement of Ebastine by Formulating Microemulsion Using D-Optimal Mixture Design: Optimization and Characterization.
    Barve AR; Kapileshwari GR; DCruz CEM; Kumar L; Bhide PJ; Mahajan AA; Arondekar AS; Shirodkar RK
    Assay Drug Dev Technol; 2022; 20(6):258-273. PubMed ID: 36070596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study.
    Shah N; Seth A; Balaraman R; Sailor G; Javia A; Gohil D
    Drug Dev Ind Pharm; 2018 Apr; 44(4):687-696. PubMed ID: 29168671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbopol emulgel loaded with ebastine for urticaria: development, characterization,
    Khan BA; Ali A; Hosny KM; Halwani AA; Almehmady AM; Iqbal M; Alharbi WS; Abualsunun WA; Bakhaidar RB; Murshid SSA; Khan MK
    Drug Deliv; 2022 Dec; 29(1):52-61. PubMed ID: 34962186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR; Faulds D
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience.
    Sastre J
    J Investig Allergol Clin Immunol; 2020; 30(3):156-168. PubMed ID: 30977465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimize preparation of compound licorice microemulsion with D-optimal design].
    Ma SW; Wang YJ; Chen C; Qiu Y; Wu Q
    Zhongguo Zhong Yao Za Zhi; 2018 Mar; 43(6):1131-1138. PubMed ID: 29676119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of microemulsion systems for dermal delivery of silymarin.
    Panapisal V; Charoensri S; Tantituvanont A
    AAPS PharmSciTech; 2012 Jun; 13(2):389-99. PubMed ID: 22350738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, characterization, and in vitro/ex vivo evaluation of quercetin-loaded microemulsion for topical application.
    Kajbafvala A; Salabat A; Salimi A
    Pharm Dev Technol; 2018 Oct; 23(8):741-750. PubMed ID: 27871215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Self-nanoemulsifying Drug Delivery System for Poorly Water Soluble Tolbutamide: Development, Optimization and Pharmacodynamic Studies.
    Pandita D; Kumari N; Lather V
    Pharm Nanotechnol; 2017; 5(4):285-300. PubMed ID: 28925888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.
    Kalis B
    Drugs; 1996; 52 Suppl 1():30-4. PubMed ID: 8828024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Tween based microemulsion in the presence of TB drug rifampicin.
    Mehta SK; Kaur G; Bhasin KK
    Colloids Surf B Biointerfaces; 2007 Oct; 60(1):95-104. PubMed ID: 17646089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microemulsion for topical delivery of fenoprofen calcium: in vitro and in vivo evaluation.
    Farghaly DA; Aboelwafa AA; Hamza MY; Mohamed MI
    J Liposome Res; 2018 Jun; 28(2):126-136. PubMed ID: 28081643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Development of Repaglinide Microemulsion Gel for Transdermal Delivery.
    Shinde UA; Modani SH; Singh KH
    AAPS PharmSciTech; 2018 Jan; 19(1):315-325. PubMed ID: 28717973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of solubility and dissolution of ebastine by fabricating phosphatidylcholine/ bile salt bilosomes.
    Islam N; Zahoor AF; Syed HK; Iqbal MS; Khan IU; Abbas G; Mushtaq M; Rehman MU; Rasul A; Ikram M; Ibrahim HM; Inam S; Irfan M
    Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2301-2306. PubMed ID: 33832904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the skin reaction to histamine by ebastine.
    Nelson HS; Bucher B; Buchmeier A; Oppenheimer J; Garcia J
    Ann Allergy Asthma Immunol; 1995 May; 74(5):442-7. PubMed ID: 7749977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of cilnidipine microemulsion.
    Tandel H; Raval K; Nayani A; Upadhay M
    J Pharm Bioallied Sci; 2012 Mar; 4(Suppl 1):S114-5. PubMed ID: 23066184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixture experiment methods in the development and optimization of microemulsion formulations.
    Furlanetto S; Cirri M; Piepel G; Mennini N; Mura P
    J Pharm Biomed Anal; 2011 Jun; 55(4):610-7. PubMed ID: 21295935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Solubility and Permeability of Salicis cortex Extract by Formulating as a Microemulsion.
    Piazzini V; Bigagli E; Luceri C; Bilia AR; Bergonzi MC
    Planta Med; 2018 Aug; 84(12-13):976-984. PubMed ID: 29689586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological study of ebastine, a novel histamine H1-receptor antagonist].
    Yakuo I; Ishii K; Seto Y; Imano K; Takeyama K; Nakamura H; Karasawa T
    Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):121-35. PubMed ID: 7511558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.